Abstract

This interim statement sets out the Joint Committee on Vaccination and Immunisation’s (JCVI) considerations and advice on the impact of extending the human papillomavirus infection (HPV) vaccination programme to adolescent boys.
The JCVI is consulting with stakeholder groups on its interim findings and once the consultation is completed will publish its final advice.
 

Recommendation Europe United Kingdom Human papillomavirus (HPV)